Sandoz Files Anti-Dumping Complaint Against Chinese Amoxicillin Imports

The Swiss drugmaker warned that unfair Chinese competition risks wiping out Europe’s last major antibiotic manufacturing base. 
Sandoz Files Anti-Dumping Complaint Against Chinese Amoxicillin Imports
Bottles of antibiotics line a shelf at a Publix Supermarket pharmacy in Miami, Fla., on Aug. 7, 2007. Joe Raedle /Getty Images
|Updated:
0:00

Swiss generic drugmaker Sandoz has filed a draft anti-dumping complaint with the European Commission over imports from China of amoxicillin active pharmaceutical ingredients, the company said on May 28.

Amoxicillin, a widely used antibiotic in the penicillin family, is commonly prescribed for respiratory, ear, and other bacterial infections. Sandoz says it operates the only major remaining vertically integrated penicillin production network in Europe, with key manufacturing steps at its site in Kundl, Austria.